milrinone and methylene blue

milrinone has been researched along with methylene blue in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Leone, RJ; Scholz, PM; Weiss, HR	1
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE	1

Reviews

1 review(s) available for milrinone and methylene blue

Article	Year
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock. Expert review of clinical pharmacology, 2022, Volume: 15, Issue:8 Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins	2022

Other Studies

1 other study(ies) available for milrinone and methylene blue

Article	Year
Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts. The Journal of surgical research, 1998, Volume: 77, Issue:1 Topics: Animals; Cyclic AMP; Cyclic GMP; Dogs; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Heart; Hemodynamics; Hypertrophy, Left Ventricular; Methylene Blue; Milrinone; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones; Reference Values	1998

Article

Year

Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts.

The Journal of surgical research, 1998, Volume: 77, Issue:1

Topics: Animals; Cyclic AMP; Cyclic GMP; Dogs; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Heart; Hemodynamics; Hypertrophy, Left Ventricular; Methylene Blue; Milrinone; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones; Reference Values

1998